Transplantation 2021 Feb 8. Epub 2021 Feb 8.
1Department of Surgery, University of California San Francisco, San Francisco, CA, USA 2Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA 3Division of Hepatology and Comprehensive Transplant Center, Northwestern Memorial Hospital, Chicago, IL, USA 4Department of Surgery, University of Pennsylvania, Philadelphia, PA, USA 5Department of Surgery, University of Michigan, Ann Arbor, MI, USA 6Department of Surgery, University of Washington, Seattle, WA, USA 7Baylor Simmons Transplant Institute, Baylor University Medical Center, Dallas, TX, USA 8Division of Gastroenterology and Hepatology, University of Colorado Denver, Aurora, CO, USA 9Immune Tolerance Network, San Francisco, CA, USA 10Division of Gastroenterology and Hepatology, University of Pennsylvania, Philadelphia, PA, USA.
Background: Deceased donor and recipient predictors of post transplant steatosis/steatohepatitis and fibrosis are not well known.
Aim: Evaluate the prevalence and assess donor and recipient predictors of steatosis, steatohepatitis, and fibrosis in LT recipients.
Methods: Using the ITN A-WISH multicenter study (NCT00135694), donor and recipient demographic and clinical features were collected. Read More